Brain‐derived neurotrophic factor knock‐out mice develop non‐alcoholic steatohepatitis
The Journal of Pathology · 2023-12 · 261 (4) · 465-476
DOI: 10.1002/path.6204 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 02.10.2023. Verfasst von Mayuko Ichimura-Shimizu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Tokushima University Graduate School, Tokushima, Japan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Core Research for Evolutional Science and Technology, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
While brain‐derived neurotrophic factor (BDNF), which is a growth factor associated with cognitive improvement and the alleviation of depression symptoms, is known to regulate food intake and body weight, the role of BDNF in peripheral disease is not fully understood. Here, we show that reduced BDNF expression is associated with weight gain and the chronic liver disease non‐alcoholic steatohepatitis (NASH). At 10 months of age, BDNF‐heterozygous ( BDNF +/− ) mice developed symptoms of NASH: centrilobular/perivenular steatosis, lobular inflammation with infiltration of neutrophils, ballooning hepatocytes, and fibrosis of the liver. Obesity and higher serum levels of glucose and insulin – major pathologic features in human NASH – were dramatic. Dying adipocytes were surrounded by macrophages in visceral fat, suggesting that chronic inflammation occurs in peripheral organs. RNA sequencing (RNA‐seq) studies of the liver revealed that the most significantly enriched Gene Ontology term involved fatty acid metabolic processes and the modulation of neutrophil aggregation, pathologies that well characterise NASH. Gene expression analysis by RNA‐seq also support the notion that BDNF +/− mice are under oxidative stress, as indicated by alterations in the expression of the cytochrome P450 family and a reduction in glutathione S‐transferase p, an antioxidant enzyme. Histopathologic phenotypes of NASH were also observed in a knock‐in mouse ( BDNF +/pro ), in which the precursor BDNF is inefficiently converted into the mature form of BDNF. Lastly, as BDNF reduction causes overeating and subsequent obesity, a food restriction study was conducted in BDNF +/pro mice. Pair‐fed BDNF +/pro mice developed hepatocellular damage and showed infiltration of inflammatory cells, including neutrophils in the liver, despite having body weights and blood parameters that were comparable to those of controls. This is the first report demonstrating that reduced BDNF expression plays a role in the pathogenic mechanism of NASH, which is a hepatic manifestation of metabolic syndrome. © 2023 The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Tokushima University Graduate School, Tokushima, Japan.
- Department of Applied Bioscience, College of Bioscience and Chemistry, Kanazawa Institute of Technology, Ishikawa, Japan.
- Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Osaka, Japan.
- Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Kawaguchi, Japan.
- Department of Anatomy and Neurobiology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
- Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Takamatsu, Japan.
ORCID-Profile: Mayuko Ichimura-Shimizu, Masami Kojima
Förderung
- Core Research for Evolutional Science and Technology
- Japan Society for the Promotion of Science
Zitieren
APA
Ichimura-Shimizu, M., Kojima, M., Suzuki, S., Miyata, M., Osaki, Y., Matsui, K., Mizui, T., & Tsuneyama, K. (2023). Brain‐derived neurotrophic factor knock‐out mice develop non‐alcoholic steatohepatitis. The Journal of Pathology, 261(4), 465-476. https://doi.org/10.1002/path.6204
Vancouver
Ichimura-Shimizu M, Kojima M, Suzuki S, Miyata M, Osaki Y, Matsui K, et al. Brain‐derived neurotrophic factor knock‐out mice develop non‐alcoholic steatohepatitis. The Journal of Pathology. 2023;261(4):465-476. doi:10.1002/path.6204
BibTeX
@article{IchimuraShimizu2023,
author = {Ichimura-Shimizu, Mayuko and Kojima, Masami and Suzuki, Shingo and Miyata, Misaki and Osaki, Yui and Matsui, Konomi and Mizui, Toshiyuki and Tsuneyama, Koichi},
title = {Brain‐derived neurotrophic factor knock‐out mice develop non‐alcoholic steatohepatitis},
journal = {The Journal of Pathology},
year = {2023},
volume = {261},
number = {4},
pages = {465--476},
doi = {10.1002/path.6204}
}
EUVIMED